Danny Sheng Wu Yeung, Chief Executive Officer at Prenetics Global Ltd (PRE), bought 78,634 shares at $18.31 ($502K) on 2026-08-20, disclosed to the SEC on 2026-08-24.
CEO Danny Yeung purchased 7,500 shares for $137,325 at $18.31, marking the largest insider purchase in the company's history. This significant buy by the CEO, occurring after six consecutive record quarters, signals strong conviction in the company's pivot to the IM8 supplement business.
The stock is currently trading at a forward P/E of -23.21, indicating the market has not yet priced in the company's recent operational turnaround and record revenue growth.
Q2 2026 earnings on August 21, 2026; Q1 2026 earnings on May 14, 2026; Benchmark initiated coverage with a Buy rating and $30 price target on June 16, 2026.
The stock faces significant valuation risk as it trades at a negative forward P/E of -23.21, and the company reported operational losses in Q1 2026 despite a 333% revenue increase.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 53,953 | $5 | 0.0% |
| 2 | $18.31 | 7,500 | $137K | 27.4% |
| 3 | $20.90 | 6,000 | $125K | 25.0% |
| 4 | $21.40 | 11,181 | $239K | 47.7% |
| Total | $6.38 avg | 78,634 | $502K | 100% |